Publicacións (49) Publicacións de Angel Salgado Barreira

2024

  1. Antibiotic Use and Antimicrobial Resistance: A Global Public Health Crisis

    Antibiotics

  2. Clinical usefulness of serum angiotensin converting enzyme in silicosis

    Pulmonology, Vol. 30, Núm. 4, pp. 370-377

  3. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient

    Inflammopharmacology, Vol. 32, Núm. 3, pp. 1805-1815

  4. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 539-546

  5. Liquid Biopsies Based on Cell-Free DNA Integrity as a Biomarker for Cancer Diagnosis: A Meta-Analysis

    Diagnostics, Vol. 14, Núm. 14

  6. Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study

    International Journal of Neuropsychopharmacology, Vol. 27, Núm. 4

  7. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  8. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology

  9. Validity and Reliability of a Questionnaire on Attitudes, Knowledge, and Perceptions of Pharmacy Students Regarding the Training Received on Antibiotics and Antimicrobial Resistance during Their University Studies

    Antibiotics, Vol. 13, Núm. 9

2023

  1. Colchicine and risk of hospitalization due to COVID-19: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 2

  2. Correlation between the main clinical, imaging, and arthroscopy findings in patients with temporomandibular disorders

    International Journal of Oral and Maxillofacial Surgery, Vol. 52, Núm. 2, pp. 237-244

  3. Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase

    Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372

  4. Effect of Previous Anticoagulant Treatment on Risk of COVID-19

    Drug Safety, Vol. 46, Núm. 3, pp. 273-281

  5. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342

  6. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 7

  7. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

  8. Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

  9. RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study

    Journal of Medical Virology

  10. Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study

    European Neuropsychopharmacology, Vol. 71, pp. 96-108

2022

  1. Decline of Tuberculosis Rates and COVID-19 Pandemic. Fact or Fiction?

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 272-274